Seideman P, Samuelson P, Neander G
Karolinska Institute, Department of Internal Medicine, Danderyd, Sweden.
Acta Orthop Scand. 1993 Jun;64(3):285-8. doi: 10.3109/17453679308993626.
In a double-blind study of 18 patients with coxarthrosis the effect of 3 naproxen doses (0.5, 1.0, and 1.5 g daily) and 2 naproxen doses combined with paracetamol (0.5 g + 4 g daily and 1.0 g + 4 g daily) was investigated. Plasma levels of naproxen and paracetamol were measured (HPLC), and clinical assessment of pain, joint movement, activity of daily life and side-effects were performed at the end of the 5 treatment periods. A relationship was found between the 3 naproxen doses, naproxen plasma levels, pain at rest, and pain during movement. The combined treatment was more effective than treatment with the same naproxen dose alone. The effect of naproxen (0.5 g daily) combined with paracetamol (4 g daily) did not differ from that obtained during treatment with higher naproxen doses only. Furthermore, the effect of the highest naproxen dose was not better than the effect of the lower naproxen dose (1.0 g daily) combined with paracetamol. The main finding was that treatment with naproxen and paracetamol is more effective than treatment with higher naproxen doses alone.
在一项针对18例髋关节炎患者的双盲研究中,研究了3种萘普生剂量(每日0.5、1.0和1.5克)以及2种萘普生剂量与对乙酰氨基酚联合使用(每日0.5克 + 4克和每日1.0克 + 4克)的效果。测定了萘普生和对乙酰氨基酚的血浆水平(高效液相色谱法),并在5个治疗期结束时对疼痛、关节活动、日常生活活动及副作用进行了临床评估。发现3种萘普生剂量、萘普生血浆水平、静息痛和运动痛之间存在关联。联合治疗比单独使用相同萘普生剂量的治疗更有效。萘普生(每日0.5克)与对乙酰氨基酚(每日4克)联合使用的效果与仅使用较高萘普生剂量治疗期间获得的效果没有差异。此外,最高萘普生剂量的效果并不优于较低萘普生剂量(每日1.0克)与对乙酰氨基酚联合使用的效果。主要发现是,萘普生与对乙酰氨基酚联合治疗比单独使用较高萘普生剂量治疗更有效。